Genital and oral mucosal immune response against HIV-1 in exposed uninfected individuals

Critical Reviews in Immunology

Volumn 29, Issue 5, 2009, Pages 369-377

  Hasselrot, Klara ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adaptive immunity; IgA; Innate immunity; T cell responses

Indexed keywords

EXPOSURE; GENITAL SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUTH MUCOSA; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 72049111744     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevimmunol.v29.i5.10     Document Type: Review

References (54)

1. The United Nations Joint Programme on HIV/AIDS [homepage on the Internet]. [cited 2009 Nov 23]. Available from: http://www.UNAIDS.org.
2. Mills E, Cooper C, Anema A, Guyatt G. Male circumcision for the prevention of heterosexually acquired HIV infection: a meta-analysis of randomized trials involving 11,050 men. HIV Med. 2008 Jul;9(6):332-335
3. Johnson LF, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. SexTransm Dis. 2008 Nov;35(11):946-959
4. World Health Organization [homepage on the Internet]. [cited 2009 Nov23]. Available from: http://www.who.org.
5. Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol. 2002 Sep;161(3):867
6. Johnson LF, Lewis DA "The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis" Sex Transm Dis. 2008 Nov; 35(11):946-59 73.
7. + T cells in transmission and acute simian immunode-eficiency virus infection. Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5640-5645
8. Neutra MR, Kozlowski PA. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol. 2006 Feb;6(2):148-158
9. Makedonas G, Bruneau J, Alary M, Tsoukas CM, Lowndes CM, Lamothe F, Bernard NF. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally. AIDS. 2005 Feb 18;19(3):251-259
10. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM. Cell-mediated immune response to human immunodefiency virus (HIV) type 1 in seronegative homosexual men with recent exposure to HIV-1. J Infect Dis. 1992 Jun;165(6):1012-1019
11. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiplyexposed individuals to HIV-1 infection. Cell. 1996 Aug 9;86(3):367-377
12. Lucotte G, Dieterlen F. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection. Infect Genet Evol. 2003 Nov;3(4):293-295
13. Campbell EM, Perez O, Melar M, Hope TJ. Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology. 2007 Apr 10;360(2):286-293
14. 13. Reynolds MR, Rakasz E, Skinner PJ, White C, Abel K, Ma ZM, Compton L, Napoe G, Wilson N, Miller CJ, Haase A, Watkins DI. CD8+ T-lymphocyte response to major immunodominant epitopes after vaginal exposure to simian immunodeficiency virus: too late and too little. J Virol. 2005 Jul;79(14):9228-9235 (Pubitemid 40934834)
15. Kaul R, Rebbapragada A, Hirbod T, Wachihi C, Ball TB, Plummer FA, Kimani J, Jaoko W. Genital levels of soluble immune factors with anti-HIV activity may correlate with increased HIV susceptibility. AIDS. 2008 Oct 1;22(15):2049-2051
16. 15. Iqbal SM, Ball TB, Kimani J, Kiama P, Thottingal P, Embree JE, Fowke KR, Plummer FA. Elevated T cell counts and RANTES expression in the genital mucosa of HIV-1-resistant Kenyan commercial sex workers. J Infect Dis. 2005 Sep 1;192(5):728-738 (Pubitemid 41193070)
17. 16. Hirbod T, Nilsson J, Andersson S, Uberti-Foppa C, Ferrari D, Manghi M, Andersson J, Lopalco L, Broliden K. Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior. J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):137-143 (Pubitemid 44454806)
18. 17. Trabattoni D, Caputo SL, Maffeis G, Vichi F, Biasin M, Pierotti P, Fasano F, Saresella M, Franchini M, Ferrante P, Mazzotta F, Clerici M. Human alpha defensin in HIV-exposed but uninfected individuals. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):455-463 (Pubitemid 38420654)
19. Levinson P, Kaul R, Kimani J, Ngugi E, Moses S, MacDonald KS, Broliden K, Hirbod T. Levels of innate immune factors in genital fluids: association of alpha defensins and LL-37 with genital infections and increased HIV acquisition. AIDS. 2009 Jan 28;23(3):309-317
20. Burgener A, Boutilier J, Wachihi C, Kimani J, Carpenter M, Westmacott G, Cheng K, Ball TB, Plummer F. Identification of differentially expressed proteins in the cervical mucosa of HIV-1-resistant sex workers. J Proteome Res. 2008 Oct;7(10): 4446-4454
21. Zapata W, Rodriguez B, Weber J, Estrada H, Quinones-Mateu ME, Zimermman PA, Lederman MM, Rugeles MT. Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals. Curr HIV Res. 2008 Nov;6(6):531-538
22. Hirbod T, Reichard C, Hasselrot K, Söderlund J, Kimani J, Bwayo J, Plummer F, Kaul R, Broliden K. HIV-1 neutralizing activity is correlated with increased levels of chemokines in saliva of HIV-1exposed uninfected individuals. Current HIV Research. 2008;6:28-33.
23. 22. Alexander R, Mestecky J. Neutralizing antibodies in mucosal secretions: IgG or IgA? Curr HIV Res. 2007 Nov;5(6):588-593 (Pubitemid 351210993)
24. Mazzoli S,Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzotta F, Clerici M. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med. 1997 Nov;3(11):1250-1257
25. Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, Kariuki C, Ngugi EN, MacDonald KS, Ball TB, Clerici M, Plummer FA. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS. 1999 Jan 14;13(1):23-29
26. Lo Caputo S, Trabattoni D, Vichi F, Piconi S, Lopalco L, Villa ML, Mazzotta F, Clerici M. Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men. AIDS. 2003 Mar 7;17(4):531-539
27. 26. Zhu T, Corey L, Hwangbo Y, Lee JM, Learn GH, Mullins JI, McElrath MJ. Persistence of extraordinarily low levels of genetically homogeneous human immunodeficiency virus type 1 in exposed seronegative individuals. J Virol. 2003 Jun;77(11):6108-6116 (Pubitemid 36588382)
28. Cerutti A. The regulation of IgA class switching. Nat Rev Immunol. 2008 Jun;8(6):421-434
29. 28.DevitoC,HinkulaJ,KaulR,KimaniJ,KiamaP,LopalcoL,BarassC,PiconiS, TrabattoniD,BwayoJJ,PlummerF,ClericiM,BrolidenK.Cross-cladeHIV-1- specificneutralizingIgAinmucosalandsystemiccompartmentsofHIV-1-exposed, persistentlyseronegativesubjects.JAcquirImmuneDeficSyndr.2002Aug1;30(4): 413-420(Pubitemid34857316)
30. Devito C, Hinkula J, Kaul R, Lopalco L, Bwayo JJ, Plummer F, Clerici M, Broliden K. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. AIDS. 2000 Sep 8;14(13):1917-1920
31. Hirbod T, Kaul R, Reichard C, Kimani J, Ngugi E, Bwayo JJ, Nagelkerke N, Hasselrot K, Li B, Moses S, MacDonald KS, Broliden K. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. AIDS. 2008 Mar 30;22(6):727-735
32. Hasselrot K, Saberg P, Hirbod T, Soderlund J, Ehnlund M, Bratt G, Sandstrom E, Broliden K. Oral HIVexposure elicits mucosal HIV-neutralizing antibodies in uninfected men who have sex with men. AIDS. 2009 Jan 28;23(3):329-333
33. 32.LopalcoL,BarassiC,PastoriC,LonghiR,BurasteroSE,TambussiG,MazzottaF, LazzarinA,ClericiM,SiccardiAG.CCR5- reactiveantibodiesinseronegativepartnersofHIV- seropositiveindividualsdownmodulatesurfaceCCR5invivoandneutralizetheinfectivit yofR5strainsofHIV-1Invitro.JImmunol.2000Mar15;164(6):3426- 3433(Pubitemid30149010)
34. 33. Belec L, Ghys PD, Hocini H, Nkengasong JN, Tranchot-Diallo J, Diallo MO, Ettiegne-Traore V, Maurice C, Becquart P, Matta M, Si-Mohamed A, Chomont N, Coulibaly IM, Wiktor SZ, Kazatchkine MD. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. J Infect Dis. 2001 Dec 1;184(11):1412-1422 (Pubitemid 33108855)
35. 34. Nag P, Kim J, Sapiega V, Landay AL, Bremer JW, Mestecky J, Reichelderfer P, Kovacs A, Cohn J, Weiser B, Baum LL. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads. J Infect Dis. 2004 Dec 1;190(11):1970-1978 (Pubitemid 39564703)
36. Kim JS, Nag P, Landay AL, Alves M, Cohn MH, Bremer JW, Baum LL. Saliva can mediate HIV1-specific antibody-dependent cell-mediated cytotoxicity. FEMS Immunol Med Microbiol. 2006 Nov;48(2):267-273
37. Castelletti E, Lo Caputo S, Kuhn L, Borelli M, Gajardo J, Sinkala M, Trabattoni D, Kankasa C, Lauri E, Clivio A, Piacentini L, Bray DH, Aldrovandi GM, Thea DM, Veas F, Nebuloni M, Mazzotta F, Clerici M. The mucosae-associated epithelial chemokine (MEC/ CCL28) modulates immunity in HIV infection. PLoS ONE. 2007 Oct 3;2(10):e969.
38. 37.KaulR,PlummerFA,KimaniJ,DongT,KiamaP,RostronT,NjagiE,MacDonaldKS, BwayoJJ,McMichaelAJ,Rowland-JonesSL.HIV-1- specificmucosalCD8+lymphocyteresponsesinthecervixofHIV-1- resistantprostitutesinNairobi.JImmunol.2000Feb1;164(3):1602- 1611(Pubitemid30067280)
39. 38. Biasin M, Caputo SL, Speciale L, Colombo F, Racioppi L, Zagliani A, Ble C, Vichi F, Cianferoni L, Masci AM, Villa ML, Ferrante P, Mazzotta F, Clerici M. Mucosal and systemic immune activation is present in human immunodeficiency virus-exposed seronegative women. J Infect Dis. 2000 Nov;182(5): 1365-1374 (Pubitemid 30800940)
40. Clerici M, Giorgi JV, Chou CC, Gudeman VK, Zack JA, Gupta P, Ho HN, Nishanian PG, Berzofsky JA, Shearer GM. Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 1992 Jun;165(6):1012-1019
41. 40. Bernard NF, Yannakis CM, Lee JS, Tsoukas CM. Human immunodeficiency virus (HlV)-specific cytotoxic T lymphocyte activity in HIVexposed seronegative persons. J Infect Dis. 1999 Mar;179(3):538-547 (Pubitemid 30016136)
42. Sriwanthana B, Hodge T, Mastro TD, Dezzutti CS, Bond K, Stephens HA, Kostrikis LG, Limpakarnjanarat K, Young NL, Qari SH, LaI RB, Chandanayingyong D, McNicholl JM. HIV-specific cytotoxic T lymphocytes, HLA-All, and chemokine-related factors may act synergistically to determine HIV resistance in CCR5 delta32-negative female sex workers in Chiang Rai, northern Thailand. AIDS Res Hum Retroviruses. 2001 May 20;17(8):719-734
43. 42.HladikF,DesbienA,LangJ,WangL,DingY,HolteS,WilsonA,XuY,MoerbeM, SchmechelS,McElrathMJ.MosthighlyexposedseronegativemenlackHIV-1-specific, IFN-gamma-secretingTcells.JImmunol.2003Sep1;171(5):2671-2683(Pubitemid37025581)
44. Suresh P, Wanchu A, Bhatnagar A, Sachdeva RK, Sharma M. Spontaneous and antigen-induced chemokine production in exposed but uninfected partners of HIV type 1-infected individuals in North India. AIDS Res Hum Retroviruses. 2007 Feb;23(2):261-268
45. 44. Suy A, Castro P, Nomdedeu M, Garcia F, Lopez A, Fumero E, Gallart T, Lopalco L, Coll O, Gatell JM, Plana M. Immunological profile of heterosexual highly HIV-exposed uninfected individuals: predominant role of CD4 and CD8 T-cell activation. J Infect Dis. 2007 Oct 15;196(8):1191-1201 (Pubitemid 47580274)
46. 45.LockettSF,RobertsonJR,BrettleRP,YapPL,MiddletonD,LeighBrownAJ. MismatchedhumanleukocyteantigenallelesprotectagainstheterosexualHIVtransmission. JAcquirImmuneDeficSyndr.2001Jul1;27(3):277-280(Pubitemid32661970)
47. 46. Hader SL, Hodge TW, Buchacz KA, Bray RA, Padian NS, Rausa A, Slaviniski SA, Holmberg SD. Discordance at human leukocyte antigen-DRB3 and protection from human immunodeficiency virus type 1 transmission. J Infect Dis. 2002 Jun 15;185(12):1729-1735 (Pubitemid 34615466)
48. Lacap PA, Huntington JD, Luo M, Nagelkerke NJ, BielawnyT, Kimani J, Wachihi C, Ngugi EN, Plummer FA. Associations of human leukocyte antigen DRB with resistance or susceptibility to HIV-1 infection in the Pumwani Sex Worker Cohort. AIDS. 2008 May 31;22(9):1029-1038
49. Boulet S, Kleyman M, Kim JY, Kamya P, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection. AIDS. 2008 Jul 31;22(12):1487-1491
50. Boulet S, Sharafi S, Simic N, Bruneau J, Routy JP, Tsoukas CM, Bernard NF. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS. 2008 Mar 12;22(5):595-599
51. 50. Lockett SF, Alonso A, Wyld R, Martin MP, Robertson JR, Gore SM, Leen CL, Brettle RP, Yirrell DL, Carrington M, Brown AJ. Effect of chemokine receptor mutations on heterosexual human immunodeficiency virus transmission. J Infect Dis. 1999 Sep;180(3):614-621 (Pubitemid 29411345)
52. 51. Suresh P, Wanchu A, Sachdeva RK, Bhatnagar A. Gene polymorphisms in CCR5, CCR2, CX3CR1, SDF-1 and RANTES in exposed but uninfected partners of HIV-1 infected individuals in North India. J Clin Immunol. 2006 Sep;26(5):476-484 (Pubitemid 44440181)
53. Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, Plummer FA. Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS. 2007 May 31;21(9):1091-1101
54. Kanari Y, Clerici M, Abe H, Kawabata H, Trabattoni D, Caputo SL, Mazzotta F, Fujisawa H, Niwa A, Ishihara C, Takei YA, Miyazawa M. Genotypes at chromosome 22q12-13 are associated with HIV-1exposed but uninfected status in Italians. AIDS. 2005 Jul 1;19(10):1015-1024